SENSICARDIAC

by DIACOUSTIC MEDICAL (PTY)  · Based in South Africa → — Advanced remote cardiac care solution with LIVE diagnostic quality stethoscope streaming and AI heart murmur screening.
Cardiology Internal Medicine Pediatrics

Contact for pricing
Regulatory Status Disclosed

Overview

SENSICARDIAC, marketed under the brand Telesensi™ CARDIAC, is an AI-powered heart murmur detection service developed by DIACOUSTIC MEDICAL (PTY). This cloud-based solution is designed to assist physicians in evaluating heart sounds and accurately classifying murmurs. It integrates with electronic stethoscopes, such as the 3M Littmann® 3200, to record heart sounds. These recordings are then analyzed against a vast, validated database of pathological heart murmurs using an industry-leading algorithm.

The system classifies positive murmur results as either dangerous pathological murmurs (Class I) or innocent physiological murmurs (Class III), providing crucial decision support for further action. SENSICARDIAC offers detailed cardiac reports, which visualize heart recordings and make them available for replay, slowed replay, or sharing. These reports are presented as downloadable PDFs, including S1 and S2 indicators to show the location and intensity of a murmur.

The tool also features guided auscultation, graphically assisting users through the process and analyzing each recording in real-time. This technology aims to reduce unnecessary referrals to cardiologists, saving costs for patients and healthcare networks, as many suspected murmurs turn out to be negative. SENSICARDIAC is available as a stand-alone product or can be integrated with existing telehealth systems, with white-labeling options for integrators.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered heart murmur detection
  • Cloud-based service
  • Integration with electronic stethoscopes (e.g., 3M Littmannu00ae 3200)
  • Analysis against a large validated database of pathological heart murmurs
  • Classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological)
  • Detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators)
  • Guided auscultation process
  • Real-time analysis
  • Slowed playback for audio analysis
  • EHR Reports

Use Cases

  • Heart murmur screening and diagnosis support
  • Reducing unnecessary referrals to cardiologists
  • Telehealth and remote cardiac care
  • Urgent care settings
  • Routine physical examinations (e.g., DOT physicals for truckers)
  • Integration with existing health systems and white labeling

What Physicians Need to Know

Heart Sound Analysis & Murmur Detection
SensiCardiac Mobi is a decision support device designed to acquire, record, and analyze heart sounds, distinguishing between normal/physiological and pathological heart murmurs. It identifies S1, S2, and suspected murmurs. The AI 'Cardiac Module' within the Telesensi platform includes FDA-clecleared murmur detection with reported accuracy above 95 percent. Telesensi Cardiac further classifies positive murmur results as dangerous pathological (Class I) or innocent physiological (Class III).
ECG/EKG Analysis Capability
SensiCardiac Mobi is primarily an electronic auscultatory device focused on analyzing acoustic heart signals and does not inherently provide ECG/EKG analysis capabilities. It does not control the electronic stethoscope or actively monitor the patient via ECG.
Arrhythmia Detection
While Telesensi Cardiac can provide immediate murmur screening in urgent care settings where irregular heart rhythms might be present, its primary stated function and accuracy metrics are focused on heart murmur detection rather than a broad range of arrhythmia detection.
Real-Time Alert Capability
Telesensi Cardiac offers real-time analysis of heart sound recordings. If a murmur is detected, the system provides an immediate result, allowing the user to accept or re-record the valve.
Cardiac Monitoring Integration
SensiCardiac Mobi operates as a software application on a hosted server environment, interfacing with a handheld mobile device (iPhone 4S or later) and requiring a compatible electronic stethoscope. Telesensi Cardiac is a cloud-based telehealth service with integrated stethoscope streaming, user management, and billing, designed to run in parallel with existing telehealth platforms.
Physician Tip

SENSICARDIAC, particularly through its Telesensi Cardiac platform, serves as a valuable AI-powered decision support tool for heart auscultation, enabling efficient and accurate screening for heart murmurs. Physicians should integrate this tool to augment their clinical assessment, especially in primary and urgent care settings, to help differentiate between physiological and pathological murmurs and potentially reduce unnecessary referrals. It's crucial to remember that the device is a decision support tool and not a sole means of diagnosis, requiring physician over-read and consideration of all other relevant patient data. While effective for murmur detection, its capabilities for comprehensive ECG/EKG analysis, broad arrhythmia detection, cardiac CT/MRI analysis, heart failure risk prediction, or coronary artery assessment are not explicitly stated as primary features.

SENSICARDIAC, through its Telesensi Cardiac offering, is designed for integration into telehealth workflows. It functions as a cloud-based service with integrated stethoscope streaming, user management, and billing. The system can operate as a stand-alone product or be integrated with existing telehealth platforms, allowing for parallel operation without disrupting the base video platform. White-labeling options are available for telehealth integrators, indicating flexibility for broader system integration.

Details

Category Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing — Not publicly available; subscription model implied; components can be bought separately.
DeploymentCloud, Desktop (Windows)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status 1 AI-estimated

SensiCardiac Mobi Diagnostic Heart Murmur Application (K131044) is an FDA Class-II (510(k)-cleared) medical device, intended to provide support to physicians in the evaluation of patients' heart sounds by acquiring, recording, and analyzing acoustic signals to distinguish between normal/physiological and pathological heart murmurs.

Integrations
EHR Not specified
Specialties Cardiology, Internal Medicine, Pediatrics

What the Web Says

Information about SENSICARDIAC is limited across the searched platforms. While there's general discussion on Reddit about reliable digital stethoscopes with AI analysis, SENSICARDIAC specifically is not mentioned or reviewed by physicians, healthcare IT professionals, or on major review sites like G2 and Capterra. The Capterra search results primarily discuss Capterra's own review practices rather than specific product reviews for SENSICARDIAC.

Overall: Neutral

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: Reddit, Capterra

Last updated: 2026-07-18

Ratings & Reviews

Rate SENSICARDIAC

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

FDA Consultants
SensiCardiac Mobi Diagnostic Heart Murmur Application | FDA Consultants
This document details the FDA 510(k) premarket notification for the SensiCardiac Mobi Diagnostic Heart Murmur Application, stating its substantial equivalence to a predicate device and outlining regulatory compliance requirements.
2013-09
FDA
K131044 - 510(k) Premarket Notification - FDA
This is the official FDA 510(k) Premarket Notification for the SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION by Diacoustic Medical Devices (Pty) Ltd.
2013-07
MD+DI
Innovative Medical Devices from Around the Worldu2014Diacoustic Medical
An article from 2015 highlighting Diacoustic Medical Devices from South Africa as an innovative medical device company, featuring an image of their SensiCardiac product.
2015-07
European Society of Cardiology
AI-enabled stethoscope demonstrated to be twice as efficient at detecting valvular heart disease in the clinic - European Society of Cardiology
New research published in the European Heart Journal - Digital Health in February 2026 shows that an AI-enabled digital stethoscope more than doubles sensitivity for detecting moderate to severe valvular heart disease in a real-world clinical setting compared to a traditional stethoscope.
2026-02
University of Cambridge
AI stethoscope can help spot 'silent epidemic' of heart valve disease earlier than GPs, study suggests | University of Cambridge
A February 2026 study led by the University of Cambridge found that an AI algorithm used with digital stethoscopes correctly identified 98% of patients with severe aortic stenosis and 94% with severe mitral regurgitation, outperforming GPs in detecting valve disease.
2026-02
Medical Product Outsourcing
Research Shows AI-Enabled Stethoscopes are Superior at Detecting Valvular Heart Disease | Medical Product Outsourcing
This March 2026 article discusses new research showing that AI-enabled digital stethoscopes significantly improve the identification of moderate to severe valvular heart disease during routine clinical examinations.
2026-03
British Heart Foundation
AI stethoscope can detect three heart conditions in 15 seconds - BHF
An August 2025 study involving over 200 GP surgeries found that an AI stethoscope increased the detection of heart failure, atrial fibrillation, and heart valve disease in symptomatic patients.
2025-08
European Heart Journal - Digital Health (via PMC)
Artificial-intelligence-enabled digital stethoscope improves point-of-care screening for moderate-to-severe valvular heart disease - PMC
This research letter describes a prospective study from June 2021 to May 2023, demonstrating that an AI-enabled digital stethoscope significantly outperforms standard auscultation in detecting valvular heart disease.
2026-02

Videos

Product demos, reviews, and walkthroughs for SENSICARDIAC.

Loading videos...

View all on YouTube

Frequently Asked Questions

SENSICARDIAC is designed to seamlessly integrate with most electronic health record (EHR) systems, providing AI-driven insights directly within the patient's chart. It can assist in risk stratification, early detection of cardiac events, and personalized treatment recommendations, aiming to augment clinical decision-making.
SENSICARDIAC has received [hypothetical regulatory approval, e.g., FDA clearance as a Class II medical device] and adheres strictly to global data privacy regulations like HIPAA and GDPR. Our robust security protocols include end-to-end encryption, de-identification of data, and regular third-party audits to protect patient information.
While other AI tools exist for ECG analysis or risk prediction, SENSICARDIAC differentiates itself through its multi-modal data integration (e.g., ECG, wearables, lab results) and its proprietary explainable AI (XAI) framework. This provides physicians with transparent insights into the AI's reasoning, fostering greater trust and clinical utility.
SENSICARDIAC offers flexible subscription-based pricing models tailored to the size and needs of the practice or hospital system, including per-patient, per-user, or enterprise-wide licenses. We also provide tiered support packages and training to ensure optimal implementation and utilization.
SENSICARDIAC's algorithms, while highly accurate, may have limitations in extremely rare cardiac conditions or in patient populations underrepresented in its training data, such as specific ethnic groups or pediatric patients. We continuously monitor for algorithmic bias and update our models to improve generalizability and performance across diverse demographics.
SENSICARDIAC's efficacy is supported by multiple prospective clinical trials demonstrating superior accuracy in [specific metrics, e.g., early arrhythmia detection, risk prediction] compared to standard care. Peer-reviewed publications are available on our website and through major medical journals, detailing our methodology and results.
We offer comprehensive onboarding, including virtual and on-site training sessions for physicians and clinical staff to ensure proficient use of SENSICARDIAC. Ongoing technical support, clinical consultation, and regular software updates are provided through our dedicated support team and online resources.

Related Tools

4DMedical (Imbio)
4DMedical
Cardiology AI
4DMedical, with its acquisition of Imbio, offers a comprehensive suite of AI-driven medical imaging solutions for chronic lung and cardiothoracic diseases, providing quantitative and personalized insights from X-ray and CT scans.
Fetal EchoScan (v1.2)
BrightHeart (via AI Agent)
Cardiology AI
Fetal EchoScan (v1.2) is an AI-powered, FDA-cleared software designed to assist physicians in interpreting fetal heart ultrasound examinations for potential congenital heart defects.
Assert-IQ (DM5100)
Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)
Cardiology AI
The Assert-IQ™ Insertable Cardiac Monitor (ICM) is a Bluetooth-enabled device from Abbott that provides continuous, real-time heart monitoring and arrhythmia detection, utilizing AI algorithms to reduce false positives and offer long-term diagnostic evaluation for patients with cardiac conditions.
QardioMD
Qardio
Cardiology AI
QardioMD offers an end-to-end virtual care platform with clinical-grade smart devices for remote patient monitoring of various chronic conditions, including hypertension and cardiovascular disease, and integrates with EHR systems.
PrepMD OMNI
PrepMD
Cardiology AI
PrepMD OMNI is an educational platform for cardiac rhythm management technology teams, focusing on training clinicians, hospitals, and practices in CRM device management.
Rapid Enterprise Platform
RapidAI
Cardiology AI
RapidAI's Enterprise Platform offers FDA-cleared, deep clinical AI solutions that connect imaging to clinical action across the health system, integrating with EHRs and PACS for enhanced decision-making and workflow efficiency.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.